Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder-Reference-Cited by-同舟云学术

Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder

Published:2023-02-07 Issue:7 Volume:8 Page:6908-6917
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Kumar Sunil¹,Oh Jong Min²,Abdelgawad Mohamed A.³⁴,Abourehab Mohammed A.S.⁵,Tengli Anand Kumar⁶,Singh Ashutosh Kumar¹,Ahmad Iqrar⁷⁸,Patel Harun⁸^ORCID,Mathew Bijo¹^ORCID,Kim Hoon²^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India

2. Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea

3. Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia

4. Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt

5. Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia

6. Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru 570015, India

7. Department of Pharmaceutical Chemistry, Prof. Ravindra Nikam College of Pharmacy, Gondur, Dhule 424002, Maharashtra, India

8. Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India

Funder

Umm Al-Qura University

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c07694

Reference53 articles.

1. Epidemiology of Parkinson's disease

2. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease

3. Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments